世界の卵巣がん市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ovarian Cancer Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4378 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、卵巣がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、化学療法、放射線、生物学的療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・卵巣がんの市場動向 ・企業の競争状況、市場シェア ・卵巣がんの種類別市場規模（手術、化学療法、放射線、生物学的療法） ・卵巣がんの用途別市場規模（病院、診療所、その他） ・卵巣がんの北米市場規模2016-2027（アメリカ、カナダ） ・卵巣がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・卵巣がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・卵巣がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・卵巣がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol Myers Squibb、Eli Lilly、GlaxoSmithKline、Janssen Pharmaceuticals、Novogen、Genentech、Aetera Zenteris、Boehringer Ingelheim、Roche） ・結論

Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer.
North America dominates the global market for ovarian cancer due to large number of aging population. Asia is expected to show high growth rates in the next five years in the global ovarian cancer market. China and India are expected to be the fastest growing ovarian cancer markets in Asia-Pacific region. Some of the key driving forces for ovarian cancer market in emerging countries are rise in healthcare expenditure, large pool of patients and rising government funding.

Market Analysis and Insights: Global Ovarian Cancer Market
The global Ovarian Cancer market size is projected to reach US$ 3102.6 million by 2026, from US$ 1637 million in 2019, at a CAGR of 9.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ovarian Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ovarian Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ovarian Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ovarian Cancer market.

Global Ovarian Cancer Scope and Market Size
Ovarian Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ovarian Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Chemotherapy
Radiation
Biological Therapy

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novogen
Genentech
Aetera Zenteris
Boehringer Ingelheim
Roche

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ovarian Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Chemotherapy
1.2.4 Radiation
1.2.5 Biological Therapy
1.3 Market by Application
1.3.1 Global Ovarian Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ovarian Cancer Market Perspective (2016-2027)
2.2 Ovarian Cancer Growth Trends by Regions
2.2.1 Ovarian Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ovarian Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Ovarian Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Ovarian Cancer Industry Dynamic
2.3.1 Ovarian Cancer Market Trends
2.3.2 Ovarian Cancer Market Drivers
2.3.3 Ovarian Cancer Market Challenges
2.3.4 Ovarian Cancer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ovarian Cancer Players by Revenue
3.1.1 Global Top Ovarian Cancer Players by Revenue (2016-2021)
3.1.2 Global Ovarian Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ovarian Cancer Revenue
3.4 Global Ovarian Cancer Market Concentration Ratio
3.4.1 Global Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ovarian Cancer Revenue in 2020
3.5 Ovarian Cancer Key Players Head office and Area Served
3.6 Key Players Ovarian Cancer Product Solution and Service
3.7 Date of Enter into Ovarian Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ovarian Cancer Breakdown Data by Type
4.1 Global Ovarian Cancer Historic Market Size by Type (2016-2021)
4.2 Global Ovarian Cancer Forecasted Market Size by Type (2022-2027)

5 Ovarian Cancer Breakdown Data by Application
5.1 Global Ovarian Cancer Historic Market Size by Application (2016-2021)
5.2 Global Ovarian Cancer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ovarian Cancer Market Size (2016-2027)
6.2 North America Ovarian Cancer Market Size by Type
6.2.1 North America Ovarian Cancer Market Size by Type (2016-2021)
6.2.2 North America Ovarian Cancer Market Size by Type (2022-2027)
6.2.3 North America Ovarian Cancer Market Size by Type (2016-2027)
6.3 North America Ovarian Cancer Market Size by Application
6.3.1 North America Ovarian Cancer Market Size by Application (2016-2021)
6.3.2 North America Ovarian Cancer Market Size by Application (2022-2027)
6.3.3 North America Ovarian Cancer Market Size by Application (2016-2027)
6.4 North America Ovarian Cancer Market Size by Country
6.4.1 North America Ovarian Cancer Market Size by Country (2016-2021)
6.4.2 North America Ovarian Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Ovarian Cancer Market Size (2016-2027)
7.2 Europe Ovarian Cancer Market Size by Type
7.2.1 Europe Ovarian Cancer Market Size by Type (2016-2021)
7.2.2 Europe Ovarian Cancer Market Size by Type (2022-2027)
7.2.3 Europe Ovarian Cancer Market Size by Type (2016-2027)
7.3 Europe Ovarian Cancer Market Size by Application
7.3.1 Europe Ovarian Cancer Market Size by Application (2016-2021)
7.3.2 Europe Ovarian Cancer Market Size by Application (2022-2027)
7.3.3 Europe Ovarian Cancer Market Size by Application (2016-2027)
7.4 Europe Ovarian Cancer Market Size by Country
7.4.1 Europe Ovarian Cancer Market Size by Country (2016-2021)
7.4.2 Europe Ovarian Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ovarian Cancer Market Size (2016-2027)
8.2 Asia-Pacific Ovarian Cancer Market Size by Type
8.2.1 Asia-Pacific Ovarian Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ovarian Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ovarian Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Ovarian Cancer Market Size by Application
8.3.1 Asia-Pacific Ovarian Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ovarian Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ovarian Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Ovarian Cancer Market Size by Region
8.4.1 Asia-Pacific Ovarian Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ovarian Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ovarian Cancer Market Size (2016-2027)
9.2 Latin America Ovarian Cancer Market Size by Type
9.2.1 Latin America Ovarian Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Ovarian Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Ovarian Cancer Market Size by Type (2016-2027)
9.3 Latin America Ovarian Cancer Market Size by Application
9.3.1 Latin America Ovarian Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Ovarian Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Ovarian Cancer Market Size by Application (2016-2027)
9.4 Latin America Ovarian Cancer Market Size by Country
9.4.1 Latin America Ovarian Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Ovarian Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ovarian Cancer Market Size (2016-2027)
10.2 Middle East & Africa Ovarian Cancer Market Size by Type
10.2.1 Middle East & Africa Ovarian Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ovarian Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ovarian Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Ovarian Cancer Market Size by Application
10.3.1 Middle East & Africa Ovarian Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ovarian Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ovarian Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Ovarian Cancer Market Size by Country
10.4.1 Middle East & Africa Ovarian Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ovarian Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Company Details
11.1.2 Bristol Myers Squibb Business Overview
11.1.3 Bristol Myers Squibb Ovarian Cancer Introduction
11.1.4 Bristol Myers Squibb Revenue in Ovarian Cancer Business (2016-2021)
11.1.5 Bristol Myers Squibb Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Ovarian Cancer Introduction
11.2.4 Eli Lilly Revenue in Ovarian Cancer Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Ovarian Cancer Introduction
11.3.4 GlaxoSmithKline Revenue in Ovarian Cancer Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Janssen Pharmaceuticals
11.4.1 Janssen Pharmaceuticals Company Details
11.4.2 Janssen Pharmaceuticals Business Overview
11.4.3 Janssen Pharmaceuticals Ovarian Cancer Introduction
11.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Business (2016-2021)
11.4.5 Janssen Pharmaceuticals Recent Development
11.5 Novogen
11.5.1 Novogen Company Details
11.5.2 Novogen Business Overview
11.5.3 Novogen Ovarian Cancer Introduction
11.5.4 Novogen Revenue in Ovarian Cancer Business (2016-2021)
11.5.5 Novogen Recent Development
11.6 Genentech
11.6.1 Genentech Company Details
11.6.2 Genentech Business Overview
11.6.3 Genentech Ovarian Cancer Introduction
11.6.4 Genentech Revenue in Ovarian Cancer Business (2016-2021)
11.6.5 Genentech Recent Development
11.7 Aetera Zenteris
11.7.1 Aetera Zenteris Company Details
11.7.2 Aetera Zenteris Business Overview
11.7.3 Aetera Zenteris Ovarian Cancer Introduction
11.7.4 Aetera Zenteris Revenue in Ovarian Cancer Business (2016-2021)
11.7.5 Aetera Zenteris Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Ovarian Cancer Introduction
11.8.4 Boehringer Ingelheim Revenue in Ovarian Cancer Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Ovarian Cancer Introduction
11.9.4 Roche Revenue in Ovarian Cancer Business (2016-2021)
11.9.5 Roche Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ovarian Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiation
Table 5. Key Players of Biological Therapy
Table 6. Global Ovarian Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ovarian Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Ovarian Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Ovarian Cancer Market Share by Regions (2016-2021)
Table 10. Global Ovarian Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Ovarian Cancer Market Share by Regions (2022-2027)
Table 12. Ovarian Cancer Market Trends
Table 13. Ovarian Cancer Market Drivers
Table 14. Ovarian Cancer Market Challenges
Table 15. Ovarian Cancer Market Restraints
Table 16. Global Ovarian Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Ovarian Cancer Market Share by Players (2016-2021)
Table 18. Global Top Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer as of 2020)
Table 19. Ranking of Global Top Ovarian Cancer Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Ovarian Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Ovarian Cancer Product Solution and Service
Table 23. Date of Enter into Ovarian Cancer Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Ovarian Cancer Revenue Market Share by Type (2016-2021)
Table 27. Global Ovarian Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Ovarian Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Ovarian Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Ovarian Cancer Revenue Market Share by Application (2016-2021)
Table 31. Global Ovarian Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Ovarian Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ovarian Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Ovarian Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bristol Myers Squibb Company Details
Table 64. Bristol Myers Squibb Business Overview
Table 65. Bristol Myers Squibb Ovarian Cancer Product
Table 66. Bristol Myers Squibb Revenue in Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 67. Bristol Myers Squibb Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Ovarian Cancer Product
Table 71. Eli Lilly Revenue in Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. GlaxoSmithKline Company Details
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Ovarian Cancer Product
Table 76. GlaxoSmithKline Revenue in Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. Janssen Pharmaceuticals Company Details
Table 79. Janssen Pharmaceuticals Business Overview
Table 80. Janssen Pharmaceuticals Ovarian Cancer Product
Table 81. Janssen Pharmaceuticals Revenue in Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 82. Janssen Pharmaceuticals Recent Development
Table 83. Novogen Company Details
Table 84. Novogen Business Overview
Table 85. Novogen Ovarian Cancer Product
Table 86. Novogen Revenue in Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 87. Novogen Recent Development
Table 88. Genentech Company Details
Table 89. Genentech Business Overview
Table 90. Genentech Ovarian Cancer Product
Table 91. Genentech Revenue in Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 92. Genentech Recent Development
Table 93. Aetera Zenteris Company Details
Table 94. Aetera Zenteris Business Overview
Table 95. Aetera Zenteris Ovarian Cancer Product
Table 96. Aetera Zenteris Revenue in Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 97. Aetera Zenteris Recent Development
Table 98. Boehringer Ingelheim Company Details
Table 99. Boehringer Ingelheim Business Overview
Table 100. Boehringer Ingelheim Revenue in Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 101. Boehringer Ingelheim Recent Development
Table 102. Roche Company Details
Table 103. Roche Business Overview
Table 104. Roche Ovarian Cancer Product
Table 105. Roche Revenue in Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 106. Roche Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ovarian Cancer Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Features
Figure 5. Biological Therapy Features
Figure 6. Global Ovarian Cancer Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Ovarian Cancer Report Years Considered
Figure 11. Global Ovarian Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Ovarian Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Ovarian Cancer Market Share by Regions: 2020 VS 2027
Figure 14. Global Ovarian Cancer Market Share by Regions (2022-2027)
Figure 15. Global Ovarian Cancer Market Share by Players in 2020
Figure 16. Global Top Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Ovarian Cancer Revenue in 2020
Figure 18. Global Ovarian Cancer Revenue Market Share by Type (2016-2021)
Figure 19. Global Ovarian Cancer Revenue Market Share by Type (2022-2027)
Figure 20. North America Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Ovarian Cancer Market Share by Type (2016-2027)
Figure 22. North America Ovarian Cancer Market Share by Application (2016-2027)
Figure 23. North America Ovarian Cancer Market Share by Country (2016-2027)
Figure 24. United States Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Ovarian Cancer Market Share by Type (2016-2027)
Figure 28. Europe Ovarian Cancer Market Share by Application (2016-2027)
Figure 29. Europe Ovarian Cancer Market Share by Country (2016-2027)
Figure 30. Germany Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Ovarian Cancer Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Ovarian Cancer Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Ovarian Cancer Market Share by Region (2016-2027)
Figure 40. China Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Ovarian Cancer Market Share by Type (2016-2027)
Figure 48. Latin America Ovarian Cancer Market Share by Application (2016-2027)
Figure 49. Latin America Ovarian Cancer Market Share by Country (2016-2027)
Figure 50. Mexico Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Ovarian Cancer Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Ovarian Cancer Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Ovarian Cancer Market Share by Country (2016-2027)
Figure 56. Turkey Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bristol Myers Squibb Revenue Growth Rate in Ovarian Cancer Business (2016-2021)
Figure 60. Eli Lilly Revenue Growth Rate in Ovarian Cancer Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Ovarian Cancer Business (2016-2021)
Figure 62. Janssen Pharmaceuticals Revenue Growth Rate in Ovarian Cancer Business (2016-2021)
Figure 63. Novogen Revenue Growth Rate in Ovarian Cancer Business (2016-2021)
Figure 64. Genentech Revenue Growth Rate in Ovarian Cancer Business (2016-2021)
Figure 65. Aetera Zenteris Revenue Growth Rate in Ovarian Cancer Business (2016-2021)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Ovarian Cancer Business (2016-2021)
Figure 67. Roche Revenue Growth Rate in Ovarian Cancer Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---